Cadila, Helperby To Join In R&D For Drugs To Fight Antibiotic Resistance
This article was originally published in PharmAsia News
Executive Summary
Cadila Pharmaceuticals and UK-based Helperby Therapeutics have agreed to engage in joint research and development of treatments for infections caused by antibiotic-resistant bacteria.